Discover 2,017 paid clinical trials in Michigan. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Michigan offers access to numerous clinical research opportunities for both healthy volunteers interested in paid studies and those with specific health conditions. Research hubs in Detroit, Grand Rapids, and Ann Arbor are enrolling participants, providing access to innovative treatments and personalized care options.
Filter
1
Filter results
Results: 2,017
Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition
Location: New Haven CT, New York NY, Miami FL, Atlanta GA,
Sponsor: University of Chicago
Sex: All
Age: 18+
Code: NCT06094478
Recruiting
Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases
Location: New York NY, Jacksonville FL, Ann Arbor MI, Chicago IL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06401356
Phase 3, Recruiting
Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms
for
T-Cell Neoplasm, Lymphoproliferative Disorders
Location: Durham NC, Columbus OH, Ann Arbor MI, Duarte CA
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 18+
Code: NCT04858256
Phase 2, Recruiting
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
for
Obstructive Sleep Apnea, OSA COPD Overlap Syndrome
Location: Detroit MI
Sponsor: VA Office of Research and Development
Sex: All
Age: 60 - 70+
Code: NCT02703207
Recruiting
Salivary Biomarkers for Non-small Cell Lung Cancer Detection
for
Lung Cancer
Location: Wynnewood PA, Warren MI
Sponsor: PeriRx
Sex: All
Age: 18+
Code: NCT02294578
Recruiting
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Boston MA, Toronto, Ann Arbor MI, Houston TX, Dallas TX,
Sponsor: LigaChem Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05941507
Phase 1, Phase 2, Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for
Ovarian Cancer
Location: Boston MA, New York NY, Paramus NJ, Bethlehem PA,
Sponsor: Daiichi Sankyo
Sex: Female
Age: 18+
Code: NCT06819007
Phase 3, Recruiting
The Use of Impella RP Support System in Patients With Right Heart Failure